GnuBIO (Cambridge, MA), a developmental-stage medical device company focused on next-generation DNA sequencing, closed a $10M Series B financing. Participants were not identified.

Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem

Request Collective IP Account Access HERE